Posted on by lowes1

A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma (D2210C00008)

Condition:   Uncontrolled Asthma
Interventions:   Biological: Tralokinumab;   Biological: Placebo
Sponsor:   AstraZeneca
Not yet recruiting – verified July 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.